Evidence map›Paper›PMID 34874923›Full record

ArticleJCI insight2022

Alveolar epithelial glycocalyx degradation mediates surfactant dysfunction and contributes to acute respiratory distress syndrome.

Alicia N Rizzo, Sarah M Haeger, Kaori Oshima, Yimu Yang, Alison M Wallbank, Ying Jin, Marie Lettau, Lynda A McCaig, Nancy E Wickersham, J Brennan McNeil and 16 more

Open access · goldAbstract read
In one paragraph

Article in JCI insight, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 54 papers.

0numbers the graph read from it
0cells of the map it votes in
54citing papers in PubMed
5.9field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

54 citing papers in PubMed, 69 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Airway macrophage specific glycocalyx expression and remodeling following viral infection.Matrix biology : journal of the International Society for Matrix Biology · 2026
    Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Review
  11. Review
  12. Review
  13. Review
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

26 authors at 10 institutions in 4 countries.

Alicia N RizzoDivision of Pulmonary Sciences and Critical Care Medicine, Department of Medicine.
Sarah M HaegerDivision of Pulmonary Sciences and Critical Care Medicine, Department of Medicine.
Kaori OshimaDivision of Pulmonary Sciences and Critical Care Medicine, Department of Medicine.
Yimu YangDivision of Pulmonary Sciences and Critical Care Medicine, Department of Medicine.
Alison M WallbankDepartment of Bioengineering, and.
Ying JinDivision of Pulmonary Sciences and Critical Care Medicine, Department of Medicine.
Marie LettauInstitute of Functional Anatomy, Charité-Universitätsmedizin, Berlin, Germany.
Lynda A McCaigDepartment of Physiology and Pharmacology, Western University, London, Ontario, Canada.
Nancy E WickershamDepartment of Medicine and Department of Pathology, Microbiology and Immunology, Vanderbilt University, Nashville, Tennessee, USA.
J Brennan McNeilDepartment of Medicine and Department of Pathology, Microbiology and Immunology, Vanderbilt University, Nashville, Tennessee, USA.
Igor ZakharevichDepartment of Biochemistry and Molecular Genetics, University of Colorado, Aurora, Colorado, USA.
Sarah A McMurtryDivision of Pulmonary Sciences and Critical Care Medicine, Department of Medicine.
Christophe J Langouët-AstriéDivision of Pulmonary Sciences and Critical Care Medicine, Department of Medicine.
Katrina W KopfDepartment of Medicine, National Jewish Health, Denver, Colorado, USA.
Dennis R VoelkerDepartment of Medicine, National Jewish Health, Denver, Colorado, USA.
Kirk C HansenDepartment of Biochemistry and Molecular Genetics, University of Colorado, Aurora, Colorado, USA.
Ciara M ShaverDepartment of Medicine and Department of Pathology, Microbiology and Immunology, Vanderbilt University, Nashville, Tennessee, USA.
V Eric KerchbergerDepartment of Medicine and Department of Pathology, Microbiology and Immunology, Vanderbilt University, Nashville, Tennessee, USA.
Ryan A PetersonDivision of Pulmonary Sciences and Critical Care Medicine, Department of Medicine.
Wolfgang M KueblerInstitute of Physiology, Charité-Universitätsmedizin, Berlin, Germany.
Matthias OchsInstitute of Functional Anatomy, Charité-Universitätsmedizin, Berlin, Germany.
Ruud Aw VeldhuizenDepartment of Physiology and Pharmacology, Western University, London, Ontario, Canada.
Bradford J SmithDepartment of Bioengineering, and.
Lorraine B WareDepartment of Medicine and Department of Pathology, Microbiology and Immunology, Vanderbilt University, Nashville, Tennessee, USA.
Julie A BastaracheDepartment of Medicine and Department of Pathology, Microbiology and Immunology, Vanderbilt University, Nashville, Tennessee, USA.
Eric P SchmidtDivision of Pulmonary Sciences and Critical Care Medicine, Department of Medicine.
Pulmonary and Critical Care Associates · USVanderbilt University · USCharité - Universitätsmedizin Berlin · DEColorado School of Public Health · USNational Jewish Health · USUniversity of Colorado Anschutz Medical Campus · USWestern University · CABioengineering Center · RUDenver Health Medical Center · USUniversity of Colorado Hospital · US

Funding

MULTIDISCIPLINARY RESPIRATORY DISEASES RESEARCH TRAININGT32HL007085 · NHLBI · UNIVERSITY OF COLORADO DENVER · PI ELLEN L BURNHAM, LISA A MAIER · 1985 to 2026
$21.6M
Role of Complement-Driven Pulmonary Vascular Inflammation in PHP01HL152961 · NHLBI · UNIVERSITY OF COLORADO DENVER · PI DELANEY, CASSIDY A · 2020 to 2024
$14.1M
PREDOCTORAL TRAINING PROGRAM IN PHARMACOLOGYT32GM007635 · NIGMS · UNIVERSITY OF COLORADO DENVER · PI DELL'ACQUA, MARK L · 1985 to 2023
$6.1M
Cardiovascular Biomechanics and Imaging in Down SyndromeT32HL072738 · NHLBI · UNIVERSITY OF COLORADO DENVER · PI SHANDAS, ROBIN · 2003 to 2025
$4.9M
NRSA Training CoreTL1TR002533 · NCATS · UNIVERSITY OF COLORADO DENVER · PI CICUTTO, LISA · 2018 to 2022
$3.0M
Targeting cell-free hemoglobin in sepsis to reduce lung microvascular permeability: mechanistic and translational studiesR01HL135849 · NHLBI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI BASTARACHE, JULIE ANNE, WARE, LORRAINE B · 2017 to 2020
$2.2M
Targeting circulating endothelial glycocalyx fragments to reduce septic encephalopathyR01GM125095 · NIGMS · UNIVERSITY OF COLORADO DENVER · PI HERSON, PACO S, SCHMIDT, ERIC PETER · 2017 to 2020
$1.9M
The Impact of Fluid Resuscitation on Glycocalyx Degradation in Septic ShockR01HL149422 · NHLBI · BETH ISRAEL DEACONESS MEDICAL CENTER · PI SCHMIDT, ERIC PETER, SHAPIRO, NATHAN I · 2019 to 2022
$1.7M
Midcareer Investigator Award in Patient-Oriented Research in Acute Lung InjuryK24HL103836 · NHLBI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI WARE, LORRAINE B · 2010 to 2020
$1.6M
Mechanisms of airspace inflammation caused by cell-free hemoglobin during ARDSK08HL136888 · NHLBI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI SHAVER, CIARA M · 2017 to 2021
$858k
Tissue-specific functional genomics in the acute respiratory distress syndromeK01HL157755 · NHLBI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI KERCHBERGER, VERN ERIC · 2021 to 2025
$845k
Epithelial glycocalyx degradation mediates surfactant dysfunction in acute respiratory distress syndromeF32HL162230 · NHLBI · UNIVERSITY OF COLORADO DENVER · PI RIZZO, ALICIA N · 2022 to 2023
$121k
NCATS NIH HHS TL1 TR002533NHLBI NIH HHS F32 HL162230NHLBI NIH HHS K01 HL157755NHLBI NIH HHS K08 HL136888NHLBI NIH HHS K24 HL103836NHLBI NIH HHS P01 HL152961NHLBI NIH HHS R01 HL135849NHLBI NIH HHS R01 HL149422NHLBI NIH HHS T32 HL007085NHLBI NIH HHS T32 HL072738NIGMS NIH HHS R01 GM125095NIGMS NIH HHS T32 GM007635
6 · The paper itself

Abstract

Acute respiratory distress syndrome (ARDS) is a common cause of respiratory failure yet has few pharmacologic therapies, reflecting the mechanistic heterogeneity of lung injury. We hypothesized that damage to the alveolar epithelial glycocalyx, a layer of glycosaminoglycans interposed between the epithelium and surfactant, contributes to lung injury in patients with ARDS. Using mass spectrometry of airspace fluid noninvasively collected from mechanically ventilated patients, we found that airspace glycosaminoglycan shedding (an index of glycocalyx degradation) occurred predominantly in patients with direct lung injury and was associated with duration of mechanical ventilation. Male patients had increased shedding, which correlated with airspace concentrations of matrix metalloproteinases. Selective epithelial glycocalyx degradation in mice was sufficient to induce surfactant dysfunction, a key characteristic of ARDS, leading to microatelectasis and decreased lung compliance. Rapid colorimetric quantification of airspace glycosaminoglycans was feasible and could provide point-of-care prognostic information to clinicians and/or be used for predictive enrichment in clinical trials.

Indexed as

GlycosaminoglycansPulmonary AtelectasisRespiratory Distress SyndromeAlveolar Epithelial CellsAnimalsDuration of TherapyFemaleGlycocalyxHumansLung Diseases, InterstitialMaleMicePredictive Value of TestsPrognosisReproducibility of ResultsRespiration, ArtificialGlycosaminoglycansGlycobiologyProteoglycansPulmonary surfactantsPulmonology

Identifiers

PMID34874923
PMCPMC8855818
OpenAlexW4200529592

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.